PMID: 18709704Aug 19, 2008Paper

Recognition of depression among women presenting with menopausal symptoms

Menopause : the Journal of the North American Menopause Society
Anita Clayton, Christine Guico-Pabia

Abstract

Depression is particularly prevalent among women in the reproductive years. This article reviews research on the risk of depression during the transition to menopause and discusses screening methods and management options. Systematic literature searches were conducted using MEDLINE (1966 to May 2007), and all relevant papers published in English were included. During the transition to menopause, most women do not experience depression, although this period represents a time of increased vulnerability for some women. Recent studies suggest that even in women without a history of depression, the risk of a new onset of depression is double or more during the menopausal transition. Certain patient factors, such as vasomotor symptoms and depression during the reproductive years, are commonly seen in gynecologic practice and are significant and independent risk factors for developing a new or recurrent episode of depression during the menopausal transition. Identifying depression in the context of menopausal symptoms may be challenging; however, various questionnaires may facilitate diagnosis. Effective short- and long-term management of depression is critical, and treatment options include antidepressant pharmacotherapy with or with...Continue Reading

References

Jul 1, 1991·The American Journal of Psychiatry·P J Schmidt, D R Rubinow
Jan 1, 1988·The American Journal of Psychiatry·E FrankD J Kupfer
Sep 15, 1986·Postgraduate Medicine·J Waxman, S M Zatzkis
Apr 5, 1985·JAMA : the Journal of the American Medical Association·S F Jencks
May 1, 1981·JAMA : the Journal of the American Medical Association·Y ErlikH L Judd
Aug 1, 1993·Psychological Medicine·S O MoldinH Akiskal
Jan 1, 1993·International Journal of Psychiatry in Medicine·D E Stewart, K M Boydell
May 1, 1993·The American Journal of Psychiatry·L J KirmayerM J Yaffe
Jul 24, 1996·JAMA : the Journal of the American Medical Association·M M WeissmanE K Yeh
Aug 1, 1996·The Journal of Nervous and Mental Disease·G Robinson
Jun 1, 1997·Journal of Women's Health·F C Lewis-HallS C Koke
Nov 10, 1998·Biological Psychiatry·H Joffe, L S Cohen
Nov 10, 1998·Biological Psychiatry·D R RubinowC A Roca
Mar 13, 1999·The Journal of Clinical Psychiatry·W F Sheeley
Oct 8, 1999·Journal of Affective Disorders·J AmsterdamC Beasley
Oct 28, 1999·The New England Journal of Medicine·G E SimonJ Ormel
Aug 15, 2000·American Journal of Obstetrics and Gynecology·P J SchmidtD R Rubinow
Aug 31, 2000·The American Journal of Psychiatry·S G KornsteinM B Keller
Jun 22, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·F MartényiS Metcalfe
Aug 4, 2001·Psychosomatic Medicine·H B BosworthI C Siegler
Aug 31, 2001·American Journal of Public Health·J T BrombergerK Sutton-Tyrrell
Oct 9, 2001·Climacteric : the Journal of the International Menopause Society·N E AvisC Longcope
Nov 13, 2001·Fertility and Sterility·M R SoulesN Woods
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·L S SchneiderC M Clary
Jan 5, 2002·Climacteric : the Journal of the International Menopause Society·M R SoulesN Woods
Mar 23, 2002·Climacteric : the Journal of the International Menopause Society·C NovaesN R de Melo
Jun 18, 2002·The Medical Journal of Australia·Anthony F JormBryan Rodgers
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Nov 20, 2002·Menopause : the Journal of the North American Menopause Society·Hadine JoffeLee S Cohen
Aug 14, 2003·American Journal of Epidemiology·Joyce T BrombergerAdriana Cordal
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Oct 30, 2003·Medical Care·Kurt KroenkeJanet B W Williams
Nov 15, 2003·BMJ : British Medical Journal·Bruce ArrollNgaire Kerse
Jan 7, 2004·Archives of General Psychiatry·Ellen W FreemanLori Hollander
Feb 13, 2004·Biological Psychiatry·Mary F MorrisonMichelle Battistini
Feb 14, 2004·Archives of Women's Mental Health·P J SchmidtM A Danaceau
Mar 12, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Robert J. GregoryNorma H. Yohai

❮ Previous
Next ❯

Citations

Jun 23, 2009·Menopause : the Journal of the North American Menopause Society·Manfred E BeutelElmar Brähler
Apr 20, 2010·Menopause : the Journal of the North American Menopause Society·Sermin Timur, Nevin Hotun Sahin
Aug 26, 2009·Women's Health·Laura J MillerRenu Gupta
Aug 27, 2010·Annals of the New York Academy of Sciences·JoAnn V Pinkerton, Dale W Stovall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.